| Leptin-and leptin receptor-deficient rodent models: relevance for human type 2 diabetes B Wang, P Charukeshi Chandrasekera, J J. Pippin Current diabetes reviews 10 (2), 131-145, 2014 | 607 | 2014 |
| Dietary selenium as a modulator of PCB 126–induced hepatotoxicity in male Sprague-Dawley rats IK Lai, Y Chai, D Simmons, WH Watson, R Tan, WM Haschek, K Wang, ... Toxicological Sciences 124 (1), 202-214, 2011 | 46 | 2011 |
| Dietary antioxidants (selenium and N-acetylcysteine) modulate paraoxonase 1 (PON1) in PCB 126-exposed rats H Shen, M Li, B Wang, IK Lai, LW Robertson, G Ludewig Environmental Science and Pollution Research 21, 6384-6399, 2014 | 24 | 2014 |
| 3-Methylcholanthrene (3-MC) and 4-chlorobiphenyl (PCB3) genotoxicity is gender-related in Fischer 344 transgenic rats JA Jacobus, B Wang, C Maddox, H Esch, L Lehmann, LW Robertson, ... Environment international 36 (8), 970-979, 2010 | 21 | 2010 |
| Mutagenicity of 3-methylcholanthrene, PCB3, and 4-OH-PCB3 in the lung of transgenic BigBlue® rats C Maddox, B Wang, PA Kirby, K Wang, G Ludewig Environmental toxicology and pharmacology 25 (2), 260-266, 2008 | 20 | 2008 |
| Species difference in the regulation of cytochrome P450 2S1: lack of induction in rats by the aryl hydrocarbon receptor agonist PCB126 B Wang, LW Robertson, K Wang, G Ludewig Xenobiotica 41 (12), 1031-1043, 2011 | 18 | 2011 |
| Dietary manganese modulates PCB126 toxicity, metal status, and MnSOD in the rat B Wang, WD Klaren, BR Wels, DL Simmons, AK Olivier, K Wang, ... Toxicological Sciences 150 (1), 15-26, 2016 | 13 | 2016 |
| Derivation of a no significant risk level (NSRL) for acrylamide B Wang, Z Guerrette, MH Whittaker, J Ator Toxicology letters 320, 103-108, 2020 | 10 | 2020 |
| Derivation of a No-Significant-Risk-Level (NSRL) for diethanolamine (DEA) B Wang, DE Amacher, MH Whittaker Regulatory Toxicology and Pharmacology 68 (1), 76-84, 2014 | 5 | 2014 |
| Mechanisitic studies of the toxicities of the aryl hydrocarbon receptor agonist PCB126 B Wang The University of Iowa, 2011 | 1 | 2011 |
| LP-49 Deriving tolerable intakes for data-poor medical device extractables: 3-Prop-2-en-1-yl propanedioate as a case study MH Whittaker, B Wang Toxicology Letters 399, S383-S383, 2024 | | 2024 |
| ToxSci Advance Access published August 24, 2011 IK Lai, Y Chai, D Simmons, WH Watson, R Tan, WM Haschek, K Wang, ... Cell 443, 212-8068, 2011 | | 2011 |
